Orange, CANCT06041594Now EnrollingIRB Ready

Pulmonary Embolism Clinical Trial in Orange, CA

Access cutting-edge pulmonary embolism treatment through this clinical trial at a research site in Orange. Study-provided care at no cost to qualified participants.

Sponsored by Innova Vascular, Inc.

Quick Self-Assessment

See if you qualify for this Orange location

Preparing your pre-screening questions…

Expert Care in Orange

Access pulmonary embolism specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related pulmonary embolism treatment provided free

Apply for This Orange Location

Check if you qualify for this pulmonary embolism clinical trial in Orange, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Orange

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Orange site if eligible
  4. 4Begin participation

About This Pulmonary Embolism Study in Orange

This is a prospective, multi-center, pivotal study to demonstrate the safety and effectiveness of the Laguna Thrombectomy System for the treatment of pulmonary embolism. The Laguna Thrombectomy System is an investigational device which consists of the Laguna Clot Retriever™ System and the Malibu Aspiration Catheter™ System. These devices are manufactured by Innova Vascular, Inc.

Sponsor: Innova Vascular, Inc.

Who Can Participate

Inclusion Criteria

≥ 18 years of age; \< 85 years old
RV/LV ratio \> 0.9 as determined by CTA
Systolic blood pressure \> 90 mmHg
Heart rate ≤ 120
Patient is deemed eligible for procedure by the interventional investigator
CTA evidence of proximal PE (filling defect in at least one main or lobar pulmonary artery)
PE Symptom duration ≤ 14 days

Exclusion Criteria

Systolic pulmonary artery pressure \> 70 mmHg on initial invasive hemodynamic assessments
Life expectancy of \< 90 days in the opinion of investigator at the time of enrollment
Subject pregnant or breast feeding
Current participation in another drug or medical device treatment study
In active chemotherapy or radiation treatment for a malignancy during the course of the study
Any intravascular administration of a fibrinolytic agent (such as Alteplase or Tenecteplase) within the last 30 days
Presence of recently placed (\<8 weeks) intracardiac devices (such as pacemaker leads) in the right ventricle or right atrium
History of prior PE within the past 90 days
FiO2 Requirement: \> 40% (6 LPM) to keep oxygen saturation \> 90%
Hematocrit: \< 28%
Platelets: \< 100,000/microliter
Serum Creatinine: \> 2 mg/dL
International Normalized Ratio (INR): \> 3
Major Trauma Injury Severity Score (ISS): \> 15
Cardiovascular or pulmonary surgery within the last 7 days
Known bleeding diathesis or coagulation disorder that cannot be managed with anti-coagulation
History of known severe or chronic pulmonary arterial hypertension
History or chronic left heart disease with left ventricular ejection fraction \< 30%
History of underlying lung disease that is oxygen dependent
History of chest irradiation
Known anaphylactic reaction to radiographic contrast agents that cannot be pretreated
Any absolute contraindication to systemic or therapeutic dosage of heparin or anticoagulants
Imaging or other evidence that suggests, in the opinion of the investigator, the subject is not appropriate for mechanical thrombectomy intervention (e.g., inability to navigate to target location, predominantly chronic clot or non-clot embolus)
Known presence of clot in transit within right atrium or ventricle

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Orange?

Yes, this clinical trial (NCT06041594) has an active research site in Orange, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Pulmonary Embolism Treatment Options in Orange, CA

If you're searching for pulmonary embolism treatment options in Orange, CA, this clinical trial (NCT06041594) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Orange research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pulmonary embolism specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all pulmonary embolism clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Orange, CA

See all pulmonary embolism clinical trials recruiting in Orange — not just this study.

Browse Pulmonary Embolism Trials in Orange →

Ready to Join in Orange?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Orange, CA